These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5918 related articles for article (PubMed ID: 3746822)

  • 1. Synthesis and evaluation of 1-(arylsulfonyl)-2-[(methoxycarbonyl)sulfenyl]-1-methylhydrazines++ + as antineoplastic agents.
    Hrubiec RT; Shyam K; Cosby LA; Sartorelli AC
    J Med Chem; 1986 Sep; 29(9):1777-9. PubMed ID: 3746822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity.
    Shyam K; Hrubiec RT; Furubayashi R; Cosby LA; Sartorelli AC
    J Med Chem; 1987 Nov; 30(11):2157-61. PubMed ID: 3669023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 2-substituted 1-methyl-1-(4-tolylsulfonyl)hydrazines as antineoplastic agents.
    Hrubiec RT; Shyam K; Cosby LA; Furubayashi R; Sartorelli AC
    J Med Chem; 1986 Jul; 29(7):1299-301. PubMed ID: 3806580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2-bis(arylsulfonyl)hydrazines. 2. The influence of arylsulfonyl and aralkylsulfonyl substituents on antitumor and alkylating activity.
    Shyam K; Furubayashi R; Hrubiec RT; Cosby LA; Sartorelli AC
    J Med Chem; 1986 Jul; 29(7):1323-5. PubMed ID: 3806585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of N,N'-bis(arylsulfonyl)hydrazines as antineoplastic agents.
    Shyam K; Cosby LA; Sartorelli AC
    J Med Chem; 1985 Apr; 28(4):525-7. PubMed ID: 3981547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars.
    Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A
    J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents.
    Shyam K; Penketh PG; Divo AA; Loomis RH; Patton CL; Sartorelli AC
    J Med Chem; 1990 Aug; 33(8):2259-64. PubMed ID: 2374151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drugs as potential antitumor agents: a selective screening study.
    Driscoll JS; Melnick NR; Quinn FR; Lomax N; Davignon JP; Ing R; Abott BJ; Congleton G; Dudeck L
    Cancer Treat Rep; 1978 Jan; 62(1):45-74. PubMed ID: 23898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.
    Shyam K; Penketh PG; Divo AA; Loomis RH; Rose WC; Sartorelli AC
    J Med Chem; 1993 Nov; 36(23):3496-502. PubMed ID: 8246218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
    MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
    J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2,3-diaziridinyl-1,4-naphthoquinone sulfonate derivatives as potential antineoplastic agents.
    Lin TS; Xu SP; Zhu LY; Cosby LA; Sartorelli AC
    J Med Chem; 1989 Jul; 32(7):1467-71. PubMed ID: 2738880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU.
    Carminati A; Barascut JL; Chenut E; Bourut C; Mathé G; Imbach JL
    Anticancer Drug Des; 1988 Jun; 3(1):57-65. PubMed ID: 3382507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential CNS antitumor agents VI: aziridinylbenzoquinones III.
    Driscoll JS; Dudeck L; Congleton G; Geran RI
    J Pharm Sci; 1979 Feb; 68(2):185-8. PubMed ID: 423089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ; Loo TL
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with AMSA on L1210 leukaemia and B16 melanoma.
    Dumont P; Atassi G; Tagnon HJ
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1017-21. PubMed ID: 6895729
    [No Abstract]   [Full Text] [Related]  

  • 18. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicine-N-oxide: the antitumor principle of Heliotropium indicum.
    Kugelman M; Liu WC; Axelrod M; McBride TJ; Rao KV
    Lloydia; 1976; 39(2-3):125-8. PubMed ID: 948236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 296.